You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
The drugmaker has partnered with Inspire and others to find study participants who have a genetic resilience to lung cancer.
With an $11.8 million award, MCGI hopes to expand patient access to experimental precision oncology treatments and develop new tools for oncologists in Maine.
